Publications

Quarterly summary of recent safety communications

Prescriber Update 41(2): 36–37
June 2020

The table below is a summary of recent safety communications to health care professionals and consumers, published on the Medsafe website.

Date	Communication	Topic
21/05/2020	Monitoring	Update - Possible risk of vasculitis with dabigatran (Pradaxa)
21/05/2020	Monitoring	Potential interaction between fluoxetine and levothyroxine
28/04/2020	Dear Healthcare Professional letter	Use of Hydroxychloroquine (Plaquenil) in the context of COVID 19 – Risk of QT prolongation and drug/drug interactions (PDF 358 KB, 4 pages)
1/04/2020	Dear Healthcare Professional letter	Supply of Typhim Vi under labelling exemption (PDF 680 KB, 2 pages)
1/04/2020	Dear Healthcare Professional letter	Discontinuation of Reopro (abciximab) 10mg/5mL solution for injection vials as of 30 June 2020 - information for healthcare professionals (PDF 78 KB, 2 pages)
27/03/2020	Alert	Mentor Siltex breast implants and anaplastic large cell lymphoma
27/03/2020	Alert	Allergan breast implants and anaplastic large cell lymphoma
12/02/2020	Dear Healthcare Professional letter	Nozinan (Swiss Stock) Change in supply of Nozinan (levomepromazine) tablets to product sourced from Switzerland - information for healthcare professionals (PDF 299 KB, 2 pages)
7/02/2020	Dear Healthcare Professional letter	Nozinan (Swiss Stock) Change in supply of Nozinan (levomepromazine) tablets to product sourced from Switzerland - information for patients (PDF 233 KB, 1 page)